株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

米国の特殊医薬品市場

The US Specialty Pharmaceutical Market: Industry Analysis & Outlook 2017-2021

発行 Koncept Analytics 商品コード 253172
出版日 ページ情報 英文 79 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.84円で換算しております。
Back to Top
米国の特殊医薬品市場 The US Specialty Pharmaceutical Market: Industry Analysis & Outlook 2017-2021
出版日: 2017年12月07日 ページ情報: 英文 79 Pages
概要

当レポートでは、米国の特殊医薬品市場について調査分析し、概要、市場規模、市場動向、競合情勢などを提供し、主要企業プロファイルも含めてお届けいたします。

第1章 市場概要

  • イントロダクション
  • 特殊医薬品 vs. 従来の医薬品
  • 特殊医薬品の用途
  • 特殊医薬品用薬局(スペシャリティファーマシー)サービス
  • 特殊医薬品の流通
  • 特殊医薬品メーカー(スペシャリティファーマ)サービス
  • 特殊医薬品用薬局(スペシャリティファーマシー)のバリュープロポジション

第2章 米国の医薬品市場分析

  • 米国の医薬品市場:収益
  • 米国の医薬品市場:収益予測
  • 米国の医薬品市場:セグメント別
  • 米国の医薬品市場における需要の成長動向
  • 米国の医薬品市場における薬剤承認:セグメント別
  • 米国の医薬品市場:薬剤別

第3章 米国の特殊医薬品市場

  • 米国の特殊医薬品市場:収益
  • 米国の特殊医薬品市場:収益予測
  • 米国の特殊医薬品市場:薬剤別
  • 米国の特殊医薬品市場:処方数

第4章 市場力学

  • 成長促進要因
  • 動向と機会
  • 課題

第5章 競合情勢

  • 米国の特殊医薬品市場
  • 米国の特殊医薬品市場:治療クラス別
  • 特殊医薬品薬局のシェア
  • 特殊医薬品の流通市場シェア

第6章 企業プロファイル

目次

The US pharmaceutical market is segregated into two types of drugs majorly i.e. traditional drugs and specialty drugs. Specialty drugs in recent times have gained a strong foothold in the US and are likely to experience robust growth in the coming years, with majority of the pharmaceutical companies heading their research and development initiatives towards these drugs.

Specialty drugs are basically meant for chronic and rare disease. Drugs in this category are very expensive and difficult to administer. Also, these drugs require proper management and special handling making them costly. Since, a large part of population in the US is ageing into diseases like cancer, and other deadly diseases, the demand for specialty drugs has skyrocketed in recent times.

The US specialty pharmaceutical market has changed over the span of five years with a lot of these drugs being in their final phase of development. The US specialty pharmaceutical market is likely to grow at staggering growth rate in the coming years majorly due to factors like ageing population of the US, improving life expectancy, rise in real net per capita medicine spending on specialty drugs, and high prevalence of chronic disease in the region.

The market is also undergoing some notable changes that have been covered in the report. The market growth is likely to be hindered by abandonment rate of specialty medicines and high R&D costs. The report offers an in-depth analysis of the "The US Specialty Pharmaceutical Market: Industry Analysis & Outlook (2017-2021)". Major pharmaceutical companies that have been covered in the report include Celgene Corporation, Gilead Sciences Inc., Amgen Inc., and AbbVie Inc.

Table of Contents

1. Market Overview

  • 1.1 Introduction
  • 1.2 Specialty Pharmaceuticals Vs Traditional Drugs
  • 1.3 Application of Specialty Pharmaceuticals
  • 1.4 Specialty Pharmacy Services
  • 1.5 Specialty Product Distribution
  • 1.6 Specialty Pharma Manufacturer Services
  • 1.7 Value Proposition of Specialty Pharmacy

2. The US Pharmaceutical Market Analysis

  • 2.1 The US Pharmaceutical Market by Value
  • 2.2 The US Pharmaceutical Market Forecast by Value
  • 2.3 The US Pharmaceutical Market by Segment
    • 2.3.1 The US Pharmaceutical Market by Segment
    • 2.3.2 The US Pharmaceutical Market by Segment Forecast
    • 2.3.3 The US Traditional Pharmaceutical Market by Value
    • 2.3.4 The US Traditional Pharmaceutical Market Forecast by Value
  • 2.4 The US Pharmaceutical Market's Demand Growth
  • 2.5 The US Pharmaceutical Market's Drug Approval by Segment
  • 2.6 The US Pharmaceutical Market by Drugs

3. The US Specialty Pharmaceutical Market

  • 3.1 The US Specialty Pharmaceutical Market by Value
  • 3.2 The US Specialty Pharmaceutical Market Forecast by Value
  • 3.3 The US Specialty Pharmaceutical Market by Drugs
  • 3.4 The US Specialty Pharmaceutical- Prescription Volume
    • 3.4.1 The US Specialty Medication Prescription Volume
    • 3.4.2 The US Specialty Medication Prescription Volume Forecast
    • 3.4.3 The US Specialty Medication Prescription Volume by Therapeutic Class
    • 3.4.4 The US Specialty Medication Prescription Volume Forecast by Therapeutic Class

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Rise in Ageing Population of the US
    • 4.1.2 Improving Life Expectancy
    • 4.1.3 Surge in Spending on Medicines
    • 4.1.4 Escalating Per Capita Heath Expenditure in the US
    • 4.1.5 Prevalence of Chronic Disease in the US
  • 4.2 Trend and Opportunities
    • 4.2.1 Technology Enabled Transformation
    • 4.2.2 Growing Foothold of Oncology Segment
    • 4.2.3 Specialty Pharmacy Mergers and Acquisitions
  • 4.3 Challenges and Issues
    • 4.3.1 High Cost of Drugs
    • 4.3.2 Abandonment Rates for Branded Medicines
    • 4.3.3 High R&D Costs

5. Competitive Landscape

  • 5.1 The US Specialty Pharmaceutical Market
    • 5.1.1 Revenue Comparison by Major Players
  • 5.2 The US Specialty Pharmaceutical Market by Therapeutic Class
    • 5.2.1 The US Specialty Inflammatory Conditions Market Share by Drugs
    • 5.2.2 The US Specialty Oncology Market Share by Drugs
    • 5.2.3 The US Specialty Multiple Sclerosis Market Share by Drugs
    • 5.2.4 The US Specialty HIV Market Share by Drugs
    • 5.2.5 The US Specialty Hepatitis C Market Share by Drugs
  • 5.3 The US Specialty Drug Pharmacies Market Share
  • 5.4 The US Specialty Product Distribution Market Share

6. Company Profiles

  • 6.1 Gilead Sciences Inc.
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 AbbVie Inc.
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Amgen Inc.
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Celgene Corporation
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • Flow of Products within the Specialty Pharmacy Channel
  • SP Benefits Model
  • The US Pharmaceutical Market by Value (2012-2016)
  • The US Pharmaceutical Market Forecast by Value (2017-2021)
  • The US Pharmaceutical Market by Segment (2016)
  • The US Pharmaceutical Market by Segment Forecast (2021)
  • The US Traditional Pharmaceutical Market by Value (2012-2016)
  • The US Traditional Pharmaceutical Market Forecast by Value (2017-2021)
  • The US Pharmaceutical Market's Demand Growth by Segment (2012-2016)
  • The US Pharmaceutical Market's Drug Approval by Segment (2016)
  • The US Specialty Pharmaceutical Market by Value (2012-2016)
  • The US Specialty Pharmaceutical Market Forecast by Value (2017-2021)
  • The US Specialty Medication Prescription Volume (2012-2016)
  • The US Specialty Medication Prescription Volume Forecast (2017-2021)
  • The US Specialty Medication Prescription Volume by Therapeutic Class (2016)
  • The US Specialty Medication Prescription Volume Forecast by Therapeutic Class (2021)
  • The US Ageing Population by Age Bracket (2012-2016)
  • The US Life Expectancy-65 Years and Above (2012-2016)
  • Total Spending on Medicines in the US (2012-2016)
  • Real Net per Capita Medicine Spending on Specialty Drugs (2012-2016)
  • Total Per Capita Health Expenditure in the US (2012-2017)
  • Prevalence of Chronic Disease in the US (2015-2030)
  • Abandonment Rates for Branded Medicines in Commercial Plans (2016)
  • The US Specialty Inflammatory Conditions Market Share by Drugs (2016)
  • The US Specialty Oncology Market Share by Drugs (2016)
  • The US Specialty Multiple Sclerosis Market Share by Drugs (2016)
  • The US Specialty HIV Market Share by Drugs (2016)
  • The US Specialty Hepatitis C Market Share by Drugs (2016)
  • Gilead Sciences Inc. Revenue Share by Product (2016)
  • Gilead Sciences Inc. Revenue and Net Income (2012-2016)
  • AbbVie Inc. Revenue Share by Products (2016)
  • AbbVie Inc. Revenue and Net Earnings (2012-2016)
  • Amgen Inc. Revenue Share by Region (2016)
  • Amgen Inc. Revenue and Net Income (2012-2016)
  • Celgene Corporation's Revenue Share by Products (2016)
  • Celgene Corporation's Revenue and Net Income (2012-2016)

List of Tables

  • Specialty Pharmaceuticals - Key Application Areas
  • Specialty Pharmacy v/s Specialty Distributors
  • The US Pharmaceutical Market by Top 10 Drugs (2016)
  • The US Specialty Pharmaceutical Market by Parameters (2016)
  • Specialty Pharmacy Mergers and Acquisitions in the US (2016)
  • Price Range of Most Expensive Specialty Drugs in the US (2016)
  • The US Specialty Pharmaceutical Market Revenue Comparison by Major Players (2016)
  • The US Specialty Drug Pharmacies Market Share (2016)
  • The US Specialty Product Distribution Market Share by Company (2016)
  • Amgen Inc. Product Developments (2016)
Back to Top